Position in MDXG
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,072,662
+$1,031,395 QoQ
Shares Held
1,317,575
+28.8% QoQ
Ownership
0.904%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 226 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. MDXG ranks #163 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in MDXG
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,072,662 | 1,317,575 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $4,041,267 | 1,023,106 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $6,878,127 | 1,015,972 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $7,487,303 | 1,072,680 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $6,667,682 | 1,091,274 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $8,696,321 | 1,144,253 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,543,708 | 1,199,970 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $6,363,680 | 1,076,765 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $7,086,921 | 1,022,644 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $8,101,600 | 1,052,156 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $9,441,657 | 1,076,586 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,805,517 | 1,070,716 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,762,603 | 1,023,087 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,421,224 | 1,003,292 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,821,261 | 1,014,843 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,874,843 | 1,001,688 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,346,618 | 964,444 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,640,885 | 985,326 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $6,233,786 | 1,032,084 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $6,271,614 | 1,034,920 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,935,625 | 1,113,959 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,805,204 | 272,350 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,649,752 | 291,823 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||